These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 4034081)

  • 1. [Bone marrow toxicity of chemotherapy combinations in operable carcinoma of the breast].
    Mano MP; Barengo R; Sinistrero G; Giurgola L; Sismondi P
    Minerva Ginecol; 1985 Jun; 37(6):335-8. PubMed ID: 4034081
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bone marrow toxicity of the chemotherapy of gynecological tumors].
    Sismondi P; Giai M; Mano MP; Catolla Cavalcanti T; Lamberto A
    Minerva Ginecol; 1985; 37(1-2):27-30. PubMed ID: 4011025
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapy induced refractory anaemia with ring sideroblasts in carcinoma breast.
    Dhot PS; Sharma MC; Kumar L; Saxena R
    J Assoc Physicians India; 1994 Feb; 42(2):153-4. PubMed ID: 7860480
    [No Abstract]   [Full Text] [Related]  

  • 4. High-dose chemotherapy with autologous stem cell rescue in women with metastatic breast cancer with involved bone marrow: a role for peripheral blood progenitor transplant.
    Myers SE; Mick R; Williams SF
    Bone Marrow Transplant; 1994 Apr; 13(4):449-54. PubMed ID: 8019470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostication of hematotoxicity for radio- and chemotherapy in patients with breast cancer].
    Ivanov SD; Iamshanov VA; Korytova LI; Khazova TV; Arzumanov AS
    Vopr Onkol; 2003; 49(5):601-7. PubMed ID: 14682132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
    de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
    Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characterization of functional disorders of bone marrow by measuring chemiluminescence].
    Reinhardt U; Reinhardt U; Rudolph E; Fleischer J
    Z Gesamte Inn Med; 1987 Jun; 42(12):341-3. PubMed ID: 3630280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose chemotherapy (HDC) with autologous bone marrow transplantation (ABMT) for the treatment of breast cancer: the jury is still out.
    Smith GA; Henderson IC
    Important Adv Oncol; 1995; ():201-14. PubMed ID: 7672807
    [No Abstract]   [Full Text] [Related]  

  • 9. [Consolidation radiotherapy after high-dose chemotherapy and autologous bone marrow transplantation in patients with advanced breast cancer].
    Rühl U
    Strahlenther Onkol; 2000 Apr; 176(4):196-7. PubMed ID: 10812394
    [No Abstract]   [Full Text] [Related]  

  • 10. [High-dose chemotherapy in carcinoma of the breast. Sunshine and shadows].
    Lelli G
    Recenti Prog Med; 2000 Dec; 91(12):647-9. PubMed ID: 11194485
    [No Abstract]   [Full Text] [Related]  

  • 11. Breast cancer: metastatic.
    Johnston S; Stebbing J
    Clin Evid; 2002 Dec; (8):1785-810. PubMed ID: 12603970
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemotherapy and concomitant irradiation in inflammatory breast cancer.
    Tubiana-Mathieu N; Lejeune C; Bonnier P; Genet D; Adjadj DJ; Berda JF; Muracciole X; Delaby F; Clavere P; Benyoub A; Rhein B; Juin B; Piana L
    Anticancer Res; 2001; 21(4B):3061-7. PubMed ID: 11712811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Persistent granulocytosis and hyperuricemia after a single G-CSF injection (Filgrastim) in treatment of chemotherapy-induced myelosuppression in metastatic breast carcinoma].
    Hofmann M; Mahlke M; Casper F; Brockerhoff P
    Zentralbl Gynakol; 1995; 117(6):314-6. PubMed ID: 7544054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer: metastatic.
    Johnston S; Stebbing J
    Clin Evid; 2002 Jun; (7):1579-602. PubMed ID: 12230774
    [No Abstract]   [Full Text] [Related]  

  • 15. [Preoperative chemotherapy of breast carcinoma].
    von Minckwitz G; Costa SD; Blohmer J; Eiermann W; Jakisch C; Tulusan AH; Kaufmann M
    Zentralbl Chir; 1998; 123 Suppl 5():138-41. PubMed ID: 10063599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relation dose efficacy in chemotherapy: the example of breast cancer].
    Chevallier B; Perrocheau G
    Bull Cancer; 1995; 82 Suppl 1():9s-15s. PubMed ID: 7626858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Subclinical heart damage caused by adjuvant anthracycline chemotherapy].
    Dunst J
    Strahlenther Onkol; 2002 Feb; 178(2):110-1. PubMed ID: 11942035
    [No Abstract]   [Full Text] [Related]  

  • 18. Selectivity in human breast cancer and human bone marrow using trimetrexate in combination with 5-fluorouracil.
    Bowen D; Johnson DH; Southerland WM; Hughes DE; Hawkins M
    Anticancer Res; 1999; 19(5B):3837-40. PubMed ID: 10628320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adjuvant systemic therapy of breast carcinoma].
    Wickramanayake PD; Katay I; Josting A; Diehl V
    Med Klin (Munich); 1996 Oct; 91(10):646-53. PubMed ID: 9019642
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-risk primary or metastatic breast cancer.
    Klein JL; Rey PM; Dansey RD; Karanes C; Du W; Abella E; Cassells L; Hamm C; Peters WP; Baynes RD
    Bone Marrow Transplant; 2000 May; 25(10):1047-52. PubMed ID: 10828864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.